ScienceDaily (Nov. 29, 2007) — It's not a cure, but this may be some
of the best news patients infected with the hepatitis C virus (HCV)
have heard in a long time: A new drug, eltrombopag, appears to be
effective in boosting low platelet counts, one of the major reasons
why patients can't endure antiviral treatments.
Full story
http://www.sciencedaily.com/releases/2007/11/071128172408.htm
Ron